1. Antibody-drug Conjugate/ADC Related
    PROTAC
  2. PROTAC-linker Conjugate for PAC

PROTAC-linker Conjugate for PAC

PROTAC-linker Conjugate for PAC comprises an antibody conjugated via a linker to a PROTAC. The PROTAC-Antibody Conjugate (PAC) molecules comprise an antibody conjugated via a linker (L1) to a PROTAC, wherein the PROTAC comprises an ubiquitin E3 ligase binding groug (“E3LB”), a linker (“L2”) and a protein binding group (“PB”). To obtain a PAC having potent efficacy and a desirable therapeutic index, the following components are provided. 1. Antibody (Ab): The antibody portion of a PAC can target a cell that expresses an antigen whereby the antigen specific PAC is delivered intracellularly to the target cell, typically through endocytosis While PACs that comprise an antibody directed to an antigen that is not found on the cell surface may result in less specific intracellular delivery of the PROTAC portion into the cell, the PAC may still undergo pinocytosis. 2. Linkers (L1): A“linker” (L1) is a bifunctional or multifunctional moiety that can be used to link one or more PROTAC moieties (D) to an antibody (Ab) to form a PAC. In some embodiments, PACs can be prepared using a L1 having reactive functionalities for covalently attaching to the PROTAC and to the antibody. 3. PROTAC(D)

.

PROTAC-linker Conjugate for PAC 相关产品 (1):

Cat. No. Product Name Effect Purity
  • HY-112100
    PAC
    PAC 是由抗体通过 linker 与 PROTAC 偶联而组成的。PAC 的详细信息请参考专利文献 WO2017201449A1 中的化合物 PAC1。与 PROTAC (无 Ab) 相比,PAC 更加显著降低雌激素受体-α (ERα) 水平。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.